Key Takeaways:
- UnitedHealth Q2 revenue hit $112 billion, beating estimates of $110.7 billion.
- Medical care ratio fell to 86.7% from 89.4% a year earlier.
- Full-year adjusted EPS guidance raised to $19.50-$20.00 from $18.25+.
Key Takeaways:

UnitedHealth Group posted $5.48 billion in Q2 net income as its medical care ratio dropped to 86.7%, driving a full-year adjusted EPS forecast of $19.50 to $20.00.
"The year-over-year decrease was driven by benefit design and pricing discipline, member mix and medical cost management initiatives," the company said in its earnings statement.
Revenue reached $112.03 billion, topping the $110.67 billion consensus estimate and edging past the $111.6 billion reported a year earlier. Net income of $6.04 per share compared with $3.74 per share in the year-ago quarter. The medical care ratio — the share of premium revenue spent on medical claims — improved 270 basis points from 89.4 percent in Q2 2025, marking the second consecutive quarter below 90 percent after hitting 91.5 percent in Q4 2025.
The improved cost picture reflects UnitedHealth's exit from unprofitable Affordable Care Act and Medicare Advantage markets, which reduced total health plan membership to 48.5 million from 49.8 million at year-end 2025. The company's roughly $1.5 billion artificial intelligence program aims to further contain costs, even as rival Elevance Health reported a 89.7 percent benefit expense ratio for the same quarter.
UnitedHealth's performance comes as the broader healthcare services sector stages a sharp rebound. Payers and payviders swung from a median year-to-date return of negative 21.7 percent at the end of Q1 to positive 31.1 percent, according to PitchBook data. The Centers for Medicare and Medicaid Services' final 2027 Medicare Advantage rate notice landed at an effective increase of approximately 5 percent, a sharp reversal from the near-flat 0.09 percent floated in January that had weighed on the sector.
The guidance raise signals management expects the cost trend to hold through year-end. Investors will watch the Q3 earnings call for updated membership numbers and further detail on the AI cost-reduction program's impact on the medical care ratio.
This article is for informational purposes only and does not constitute investment advice.